Kidder Stephen W Abb Vie Inc. Transaction History

Kidder Stephen W

$333 Million
Q3 2024

A detailed history of Kidder Stephen W transactions in Abb Vie Inc. stock. As of the latest transaction made, Kidder Stephen W holds 13,096 shares of ABBV stock, worth $2.33 Million. This represents 0.78% of its overall portfolio holdings.

Number of Shares

13,096

Previous 13,216 0.91%

Holding current value

$2.33 Million

Previous $2.27 Million 14.12%

% of portfolio

0.78%

Previous 0.72%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$163.84 - $199.33 $19,660 - $23,919	-120 Reduced 0.91%	13,096 $2.59 Million
Q2 2024 Aug 12, 2024	SELL	$154.79 - $180.76 $17,026 - $19,883	-110 Reduced 0.83%	13,216 $2.27 Million
Q1 2024 May 13, 2024	SELL	$159.82 - $182.1 $127,856 - $145,680	-800 Reduced 5.66%	13,326 $2.43 Million
Q4 2023 Feb 13, 2024	SELL	$137.6 - $154.97 $51,049 - $57,493	-371 Reduced 2.56%	14,126 $2.19 Million
Q3 2023 Nov 14, 2023	SELL	$133.59 - $154.65 $62,787 - $72,685	-470 Reduced 3.14%	14,497 $2.16 Million
Q2 2023 Aug 11, 2023	SELL	$132.51 - $164.9 $67,315 - $83,769	-508 Reduced 3.28%	14,967 $2.02 Million
Q1 2023 May 10, 2023	SELL	$144.61 - $166.54 $85,319 - $98,258	-590 Reduced 3.67%	15,475 $2.47 Million
Q4 2022 Feb 09, 2023	BUY	$138.31 - $165.87 $330,560 - $396,429	2,390 Added 17.48%	16,065 $2.6 Million
Q3 2022 Nov 08, 2022	SELL	$134.21 - $153.93 $35,565 - $40,791	-265 Reduced 1.9%	13,675 $1.84 Million
Q2 2022 Jul 19, 2022	SELL	$137.62 - $174.96 $216,751 - $275,562	-1,575 Reduced 10.15%	13,940 $2.14 Million
Q1 2022 May 17, 2022	SELL	$131.98 - $163.75 $76,812 - $95,302	-582 Reduced 3.62%	15,515 $2.52 Million
Q4 2021 Feb 08, 2022	SELL	$107.43 - $135.93 $447,768 - $566,556	-4,168 Reduced 20.57%	16,097 $2.18 Million
Q3 2021 Nov 10, 2021	SELL	$106.4 - $120.78 $4,788 - $5,435	-45 Reduced 0.22%	20,265 $2.19 Million
Q2 2021 Aug 09, 2021	BUY	$105.21 - $117.21 $138,351 - $154,131	1,315 Added 6.92%	20,310 $2.29 Million
Q1 2021 May 17, 2021	SELL	$102.3 - $112.62 $21,483 - $23,650	-210 Reduced 1.09%	18,995 $2.06 Million
Q4 2020 Feb 16, 2021	SELL	$80.49 - $108.67 $201,225 - $271,675	-2,500 Reduced 11.52%	19,205 $2.06 Million
Q3 2020 Oct 28, 2020	SELL	$85.91 - $100.83 $8,591 - $10,083	-100 Reduced 0.46%	21,705 $1.9 Million
Q2 2020 Jul 28, 2020	SELL	$73.37 - $98.18 $45,416 - $60,773	-619 Reduced 2.76%	21,805 $2.14 Million
Q1 2020 May 07, 2020	SELL	$64.5 - $97.79 $14,512 - $22,002	-225 Reduced 0.99%	22,424 $1.71 Million
Q4 2019 Jan 15, 2020	SELL	$72.13 - $90.25 $3,606 - $4,512	-50 Reduced 0.22%	22,649 $2 Million
Q3 2019 Nov 07, 2019	BUY	$62.98 - $75.72 $22,987 - $27,637	365 Added 1.63%	22,699 $1.72 Million
Q2 2019 Jul 24, 2019	SELL	$65.7 - $83.98 $4,861 - $6,214	-74 Reduced 0.33%	22,334 $1.62 Million
Q1 2019 May 01, 2019	SELL	$77.14 - $90.79 $566,979 - $667,306	-7,350 Reduced 24.7%	22,408 $1.81 Million
Q4 2018 Jan 24, 2019	SELL	$77.85 - $96.01 $149,082 - $183,859	-1,915 Reduced 6.05%	29,758 $2.74 Million
Q3 2018 Oct 15, 2018	SELL	$88.91 - $98.84 $20,893 - $23,227	-235 Reduced 0.74%	31,673 $3 Million
Q2 2018 Jul 30, 2018	SELL	$89.78 - $106.23 $99,655 - $117,915	-1,110 Reduced 3.36%	31,908 $2.96 Million
Q1 2018 Apr 24, 2018	SELL	$92.01 - $123.21 $356,078 - $476,822	-3,870 Reduced 10.49%	33,018 $3.13 Million
Q4 2017 Feb 02, 2018	SELL	$89.56 - $98.21 $74,782 - $82,005	-835 Reduced 2.21%	36,888 $3.57 Million
Q3 2017 Oct 26, 2017	BUY	$69.85 - $89.22 $2.63 Million - $3.37 Million	37,723	37,723 $3.35 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $315B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kidder Stephen W, based on Form 13F filings with the SEC.

News

Stay updated on Kidder Stephen W with notifications on news.

Account